| Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured £3.5m in new equity financing, including £2.5m from lead investor |
WIF... tsiL esreviD-redneG nO maeT emMaple... semalF gnitegraT & snoitpO tfaSNGPL... arazaH ni tfeht sag tsniaga evWhy... trats toh eunitnoc ot dib ni yInjured... rataQ ni secar PGotoM gninepoSebi... gnidart ogla ni noitapicitrapCo-op... kcatta rebyc retfa erab sevlehReece... notrevE ta emag s'aeslehC gnirUAAP... niw thgairts driht rof UEF ffoComparação... ocinú oãt onamuh orberéc o zaf